United States Court of Appeals
for the Federal Circuit
______________________
IN RE: VIVINT, INC.,
Appellant
______________________
2020-1992
______________________
Appeal from the United States Patent and Trademark
Office, Patent Trial and Appeal Board in No. 90/020,115.
______________________
Decided: September 29, 2021
______________________
WILLIAM MILLIKEN, Sterne Kessler Goldstein & Fox,
PLLC, Washington, DC, argued for appellant. Also repre-
sented by JASON DANIEL EISENBERG, ROBERT GREENE
STERNE.
ROBERT J. MCMANUS, Office of the Solicitor, United
States Patent and Trademark Office, Alexandria, VA, ar-
gued for appellee Andrew Hirshfeld. Also represented by
THOMAS W. KRAUSE, MAUREEN DONOVAN QUELER,
FARHEENA YASMEEN RASHEED.
______________________
Before MOORE, Chief Judge, SCHALL and O’MALLEY,
Circuit Judges.
MOORE, Chief Judge. In 2011, Congress passed the Leahy-Smith America In- vents Act (AIA), Pub. L. No. 112-29, 125 Stat. 284 (codified
Case: 20-1992 Document: 39 Page: 2 Filed: 09/29/2021
2 IN RE: VIVINT, INC. in scattered sections of title 35). Overhauling the patent system, Congress created new ways to reexamine the va- lidity of issued patents. See id. “[I]n the post-AIA world, a patent can be reexamined either in federal court during a defense to an infringement action, in an ex parte reexami- nation by the Patent Office, or in the suite of three post- issuance review proceedings before the Patent Trial and Appeal Board.” Return Mail, Inc. v. U.S. Postal Serv., 139 S. Ct. 1853, 1860 (2019). Often, parties use multiple path- ways to challenge validity. For example, an accused in- fringer may challenge validity both in district court and in an inter partes review (IPR), one of the three post-issuance review proceedings. This case requires us to determine when one pathway, ex parte reexamination, is available to a requester who has repeatedly tried to use another pathway, IPR, to forward the same arguments. By statute, the Patent Office must find a “substantial new question of patentability” before or- dering reexamination, 35 U.S.C. § 303(a), and it may deny reexamination when “the same or substantially the same prior art or arguments previously were presented to the Of- fice,” 35 U.S.C. § 325(d). 1 While the ex parte reexamination in this case was based on substantial new questions of pa- tentability, the Patent Office abused its discretion and 1 Both statutes refer to the Patent Office’s Director. 35 U.S.C. §§ 303(a) (“[T]he Director will determine whether . . . .”), 325(d) (“[T]he Director may . . . reject the petition . . . .”). But the Director has delegated the § 303(a) inquiry to examiners. See 37 C.F.R. § 1.515. And the Office of Pa- tent Legal Administration (OPLA), a subset of the Patent Office, resolved Vivint’s petitions that raised § 325(d). See 37 C.F.R. § 1.181(a) (allowing for petitions invoking the Di- rector’s supervisory authority), 1.181(g) (allowing for dele- gation of review of such petitions). The parties treat each entity as an arm of the Patent Office, and we do the same. Case: 20-1992 Document: 39 Page: 3 Filed: 09/29/2021 IN RE: VIVINT, INC. 3 acted arbitrarily and capriciously under § 325(d). Thus, we vacate and remand with instructions for the Patent Office to dismiss. [2] BACKGROUND In 2015, Vivint sued Alarm.com for infringing four pa- tents, including U.S. Patent No. 6,717,513. While defend- ing itself in district court, Alarm.com requested the Patent Office institute a litany of post-issuance review proceed- ings. In total, Alarm.com filed fourteen IPR petitions. Three of those petitions—IPR2015-01997, IPR2016-00129, and IPR2016-01091—challenged the validity of claims in the ’513 patent, which is the only patent at issue here. The Patent Office ultimately declined to institute IPR for the ’513 patent. For the ’997 and ’129 petitions, the Pa- tent Office determined that Alarm.com failed to make the threshold showing for institution: a reasonable likelihood that it would prevail on at least one challenged claim. See 35 U.S.C. § 314(a). For the ’091 petition, however, the Pa- tent Office declined institution on a different basis. It viewed the ’091 petition as an example of “undesirable, in- cremental petitioning.” Alarm.com Inc. v. Vivint, Inc., IPR2016-01091, Paper 11, at 12 (P.T.A.B. Nov. 23, 2016) (’091 Decision). Alarm.com had “used prior Board decisions as a roadmap to correct past deficiencies.” Id. And the Pa- tent Office reasoned that “allowing similar, serial chal- lenges to the same patent, by the same petitioner, risks harassment of patent owners and frustration of Congress’s intent in enacting the Leahy-Smith America Invents Act.” Id. (internal quotation marks and alterations omitted). To discourage such petitioning, the Patent Office exercised its discretion to deny institution for the ’091 petition. Id.
[*1]In dismissing and denying Vivint’s § 1.181 petitions, the Patent Office relied primarily on its alleged lack of au- thority to terminate an ex parte reexamination. See J.A. 10847. We do not agree with the Patent Office’s assess- ment of its authority. The Patent Office has authority to reconsider its decision ordering ex parte reexamination based on § 325(d). “The power to reconsider is inherent in the power to decide.” Tokyo Kikai Seisakusho, Ltd. v. United States, 529 F.3d 1352, 1360 (Fed. Cir. 2008). We have applied that principle to hold the Patent Office has authority to reconsider IPR institution decisions. See, e.g., Medtronic, Inc. v. Robert Bosch Healthcare Sys., Inc., 839 F.3d 1382, 1385 (Fed. Cir. 2016); cf. GTNX, Inc. v. INTTRA, Inc., 789 F.3d 1309, 1313 (Fed. Cir. 2015). We reasoned that “nothing in the statute or regulations applicable [to CBMs] clearly deprives the Board of that default author- ity.” GTNX, Inc., 789 F.3d at 1313. And we likewise see
Case: 20-1992 Document: 39 Page: 13 Filed: 09/29/2021
IN RE: VIVINT, INC. 13 nothing in the statutes or regulations preventing the Pa- tent Office from reconsidering a decision ordering ex parte reexamination. See, e.g., 35 U.S.C. §§ 301–07 (governing ex parte reexamination); 37 C.F.R. § 1.183 (allowing for waiver of Patent Office rules). Thus, the Patent Office abused its discretion by denying Vivint’s § 1.181 petitions based on a contrary legal conclusion: that the Patent Office did not have authority to consider those petitions. While the Patent Office purported to consider Vivint’s § 325(d) arguments on the merits, its legal error infected that analysis. In its first § 1.181 decision, the Patent Office held that it did “not have the discretion to terminate an ongoing reexamination on the basis set forth in 35 U.S.C. [§] 325(d) if no petition requesting such relief is filed until after reexamination has been ordered.” J.A. 10847 (empha- sis in original). And that holding drove the Patent Office’s dismissal decision. See J.A. 10856. The remainder of the first decision included “additional comments . . . in order to clarify [Patent] Office policy,” but those comments were tangential to the Patent Office’s decision. J.A. 10847. In- deed, the Patent Office reincorporated its erroneous legal conclusion into its policy conclusions. J.A. 10853 (“For all of the reasons set forth above, the determination by the [Patent] Office not to exercise its discretion under [§ 325(d)] in the present ex parte reexamination proceeding is not inconsistent with [IPR] practice.” (emphasis added)). The Patent Office’s second § 1.181 decision proceeded in much the same way. See J.A. 12210–19. The Patent Office stressed that Vivint “had the opportunity . . . to file a petition limited to issues involving 35 U.S.C. [§] 325(d) prior to the issuance of the order for reexamination, but chose not to do so.” J.A. 12213, 12217. And it faulted Vivint for failing to seek waiver of the Patent Office rules that prevented such a filing. To be sure, the second § 1.181 decision mentioned Vivint’s § 325(d) arguments. And the Patent Office concluded that it had “reviewed the record and declined to reject the request [for ex parte Case: 20-1992 Document: 39 Page: 14 Filed: 09/29/2021 14 IN RE: VIVINT, INC. reexamination] under [§ 325(d)]” at the outset of the ex parte reexamination. J.A. 12217. But at the same time, the Patent Office again relied on its erroneous legal conclu- sion: “that once the [ex parte reexamination] order has is- sued, the Office is required by statute to conduct reexamination.” J.A. 12217. And like its decision on the first § 1.181 petition, the Patent Office incorporated its le- gal error into its ultimate conclusion. J.A. 12217 (“For all the reasons set forth above, patent owner’s [petition] is de- nied.” (emphasis omitted)). 6 Our finding that the Patent Office misunderstood the scope of its authority to terminate reexamination once in- stituted would normally prompt us to vacate the Patent Of- fice’s decision so that it may exercise the authority as now properly understood. Doing so in this case would be a waste of everyone’s resources, however. It would be arbi- trary and capricious for the Patent Office to do anything on remand other than terminate the reexamination. Agency action that “departs from established precedent without a reasoned explanation [is] arbitrary and capricious.” Fred Beverages, Inc. v. Fred’s Cap. Mgmt. Co., 605 F.3d 963, 967 (Fed. Cir. 2010) (holding Trademark Trial and Appeal Board acted arbitrarily by denying leave when “[t]here [wa]s no basis on which to distinguish the circumstances of the present case from those in which” leave was granted). After the ’091 Decision, it was unreasonable for the Patent
[*2]